Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is an FDA approval action for a generic clomiphene citrate formulation; it confirms regulatory authorization but does not report clinical trial outcomes or comparative efficacy.